Invicta Diagnostic announces price range at Rs 28-cr SME IPO opening on December 1

Invicta Diagnostics, which runs PC Diagnostics, said on Thursday that its Rs 28.12 crore IPO will open for public subscription on December 1.The initial public offering (IPO) will close on December 3 and bids for anchor investors will open for a day on November 28, Mumbai-based Invicta Diagnostic said in a statement.

The company has set a price range of Rs 80-85 per equity share, it added.The IPO is entirely a fresh issue of 33.08 lakh shares, amounting to Rs 28.12 crore.

The net proceeds of the fresh issue worth Rs 21.11 crore will be used for purchase of medical equipment for setting up five new diagnostic centers in Maharashtra. Part of the proceeds will also be used for general corporate purposes.

Founder and MD of Jeena Sikho Lifecare, Acharya Manish Grover, owned 1.37 percent stake in Invicta Diagnostic. According to its red herring prospectus (RHP), the company offers a range of approximately 60 routine and 487 specialist pathology tests and approximately 96 basic and 130 advanced radiological tests covering a range of specialties and disciplines. On the financial front, Invicta Diagnostic reported revenues of Rs 16.94 crore and profit after tax (PAT) of Rs 4.08 crore in the quarter ended September 2025. The company posted revenues of Rs 30.09 crore and PAT of Rs 4.92 crore in FY25.

The company’s shares are proposed to be listed on the NSE Emerge platform.

Socradamus Capital Pvt Ltd is the sole book running lead manager for the IPO